Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2779 (LINC02779) is an RNA gene classified as a long intergenic non-coding RNA, meaning it produces a transcript longer than 200 nucleotides that does not code for a protein and does not overlap known coding regions in the genome[3]. The specific function of LINC02779 has not yet been experimentally validated or ascribed in gene/protein function databases or in the biomedical literature[1]. In general, lincRNAs are known to act through various mechanisms, including modulating chromatin structure, regulating transcription of neighboring or distal genes, RNA stabilization, and sometimes possessing enhancer-like activities[3]. Only a subset of annotated lincRNAs has been functionally characterized to date, and many, like LINC02779, remain of unknown specific biological significance.
Not applicable (not a known or established drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2779 (LINC02779).